- 1 - 平成25年7月24日判決言渡 平成24年（行ケ）第10206
Contents
1. 2039 7 3 1 0 1 0 No 6 3 a 12. 5 2 2 2
3. 2 3 5 2
4. 1 2 1 3 3 2 1 2 b 1 2
5. 8 1 2 2 6 8 1 2 2 6
6. 39 1 7 3 2 3 7 3 2
7. 4 3 R S 2 S 3 5 3 1 3 1
8. homologous P CA S R S 5 S
9. 2 4 1 3 a 1 Ar 9 r Ar A r A k 2 6 B 2 1 6 3 7 b
10. A 2 2 4 2 2 CHIRALCE nn 46 4
11. A HPLC HIRALCEL OD CHIRALPAK AD C 1 3 1 R S 2 R 2 5
12. R S I 20 8 0040 004
13. 6 7 2 6 7 3 1 1 2 6 7 3 AL 0022
14. 27 S R
15. 2 1 UI 83 S R 9 4 S 7 2 2 S R 2
16. R R 2 2 S 2 22 lt 50 R 6
17. 2 CHIRALPAK AD 7 3 2
18. 6 40 8 6 8
19. 1 2 1 HPLC CHIRALCE L OD CHIRALPAK AD 3 0 1 1 2 R S
20. 28 S Blaschke
21. p 4 5 3 1 6 C 4 4 4 2 1 4 1 6 7 8 7 1 C 1mg kg 1 0 0 2 1 3 4 4 2 1 1 00 1m 1
22. 9 6 HPLC 35 5 4 7 1 0 5 75 1 7 5 1 HPLC
23. 4 1 R S 2 5 2 2 51 6
24. 3 5 35 42 35 34 34 35 8 0 570 4 2 5 b 5 3 2 5 2 5 2 5 6 3 4 4 3 5 3 5
25. 4 4 4 2 1 3 1 0 1 c I Ar Ar 4 1 3 1 6 d I 23 Ee f 2
26. No 6 5 4 5 4 5 4 7 7 1 0 5 25 5 7 5 1 7 5 1 HH PL C 7 6 2 HPLC 0 1
27. 0 19 v v Max 1 0 0 1 v v Max 0 5 7 3 2 CHIRALPAK AD n 2 n
28. S S 2 S 2 8 8 8 8 25 3 5 8 2 8 3
29. HPLC v CHIRALCEL OD CHIRALPAK AD 9
30. 1 1 1 3 1 0 1 3 8 3 R S 3 7 7 8 78 R S
31. HPLC 1 0 1 0 0 3 7 5 1 2 0 7 5 1 8 1 2 26 30
32. 31 5 1 3
33. 5 0 9 6 5 1 0 0 8 6
34. ul b S D R R S 2
35. 1 47 5 R S 1 S R 4 3 homologous P C A S R 1 0 0 0 030 0 0 3 5 S R S 0048 9 4
36. 478 11 3 5 8 480 1 43 7 6 2 5 6 34 2 5 CH I RALCEL OD 6 35 2 5 CH I RALPAK AD a b 1 CHIRALCEL OD 1 CHIRALPAK AD 500 8 0
37. 0 1 0 1 CHIRALPAK AD n 2 lt
38. 8 HPLC CHIRALCEL OD CHIRALPAK AD
39. 5 0 9 6 5 1 3 8 6
40. 8 CHIRALPAK AD OO 3 4 7 7 3 2 3 1 9 95 7 9 3 HPLC 1996 8 2 CHIRALPAK AD 2 3 CHIRALCEL OD CHIRA
41. 5 0 1 50 1 6 3 4 2 1 0 NO 2 26 1 1 1
42. 5 3 5 0 8 1 2 2 6 3 8 8 2 5 35 8 2 8
43. 1 2 9 1 3 2 2 1 3 1 2 Du kal 2 3 2 9 1 3 2 2 2 1 2 4 4 4 2 9 1
44. 4 4 4 2 4 4 4 2 4 4 4 2 1 R S 2 4 4 4 2 3 1 2
45. 5 6 CHIRALCEL OD CHIRALPAK AD OO 12 4 S CHIRALPA K AD CHIRALCEL OD 7 3 1 5 5 6 6 5 3 2 5 25 6 3 2 5
46. 2 S 50 1 0 7 2 1 3
47. S 2 S 2 3 6 2 2 S
48. 1 S R 9 4 3 S 4 S 49 1 S R
49. 377 9 31 HPLC 3 7 7 2 1 5 a 36 2 5 4 HPL C 7 5 1 7 HPLC
50. HPLC 7 HPLC 8 1 2 26 HPLC 0 1
51. 3 S 7 4 S 3 S R 2 S 2 48
52. 1 S 4 4 4 2 0001 f 422 5465 2 O CI 14 A
53. 2 1 000 2 0004 2 5 4 311 336 1989
54. 1 2 7 1 DL 1 1 1 1 7 1 1 DL 4 1 a b I S el 1 gt CS 19 0036 0039 4 4
55. 1 R S 4 4 4 2 2 R S 4 4 4 2 1 3 1 2 3 1 1 2 25465 63 175 1 4 2 1 7 2 4 2 6 2 2 2 2
56. S 4 4 4 2 2 2 5 0 0m 40C 75 1 R 4 S 1 1 1 96 1 72 2 65 0 15 0 16 20 1 20 R 0 87 1 15 0 37 0 39 0 37 0 40 0 45 0 18 0 05 4 S R
57. 7 3 2 3 CHIRALPAK AD n 2 0 1 HPLC 0 1
58. CHIRALCEL OD CHIRALPAK AD Type IL 6 4 CHIRALCEL OD CHIRALPAK AD 6 4 6 4 CSP CSP CS P 45 4 6
59. 4 5 3 10 5 4 4 3 1 HPLC V
60. 2 6 7 2 2 2 S
61. 2 2 2 S 2 2 2 1 HPLC
62. 2 4 93 2 2 7 8 6 313 493 0 63 3 5 3 7 2 108 9 8 2 3 5 4 9 3 1 8 5 7 8 1 2 8 3 9 1 7 9
63. 73 2 73 1 73 2 7 9 7 3 2 8 2 CHIRALPAK AD 37 7 3 2 2 2 80 20 v v 3 nm 2 1 0 0 0 0 100 v v nn 100 0 8 5 15 50 50 0 100 v v 100 0 8 5 15 35 65 0 100 v v 40 2
64. B 1 te 2 2 7 5 60 94 962 61 19406 2 3 2 22
65. 3 6 6 1 2 2 S 33 2 S 2 2
66. 5 4 5 4 34 1
67. 2 3 kal 0 97 5 9 2 3 6 9 2 4 4 2 3 19 50784 2 8 6 1 1 3 2011 800 1 ls 1 1 2 3
68. CHIRALCEL OD CHIRALPAK AD 44 1 2 5 5 0 0 CHIRALCEL O D CHIRALPAK AD C HIRALCEL OD CHIRALPAK AD 5 0 0 CH IRALCEL OD CHIRALPAK AD
69. 1 0 1 0 0 3 7 5 13 2 0 HPLC
70. 6 7 3 2 2 S S gt 10 2 2 1 7 5 1 3 7 6 1 7 20
71. 0005 xz 1 S 4 4 4 2 00061 a 15 S R Wa S S 4 4 4 2 3 R R 4 4 4 2
72. 2 2 8 1 5 4 1 S 2 S 3 R S 3
73. 8 OO 32 6 8 2 8 v o S
74. 29 1 3 3 xz 7 10 5 75 1 7 5 1 1
75. 3 3 18 x 3 3 I 8S 2 1 2 1 1 2
76. 2 1 2 4 4 4 2 H NMR CDC 1 3 6 ppm 1 84 1 98 6H b m 2 58 2H t 2 73 4H b m 2 92 2H b 3 68 1H m 7 17 7 22 7H m 8 51 1H m 11 3 1 1H b 8 20 9 25 1 5 2 g 4 2 e f 3 6 2 1 0 1 Vol 29 No 1 1 0 4
77. a A B 2 2 1 7 2 2 1 21 Ar 0 Xcar o A C Ar Ar Ar b 5 1 1 8 i 2 lt 6 A
78. 7 benzylpenicil11oy1 bovine serum albumin B PO BSA 500g 19 Evans Blue 1 m1 P CA 3 0 1 6 h 2 2 2 2 7 homologousP CA tmg kg p o nh 9 0 01 10 37 3 0 02 8 46 3 8 0 03 9 56 9 0 06 8 63 4 0 1 8 58 8 0 3 8 3 1 1 0 8 13 6 0 95204 3 0 8 45 8 10 0 8 59 5 nhn 1 S R S R ED 0 0 2 3mg kg 1 0mg kg S R 4 3 2 PCA S
79. R 17 7 0 50 3 5 S R 1 0 0 S R 0030 0035 b S 4 S I S S I S 1 1I S
80. S lt 4 2 2 R S 2 1 1 2 1 1 2 1 S 2 1 S 2
81. 8 m 1 2 g 2 4 8 50 24 3 4 4 2 1 0 86g 9 2 3 a 4 4 2 4 98g 16 45 4 3 85g 19 74 3 5m 1 2 73g 19 75 4 4 4 4 2 1 6 26g 91 4 3 4 4 4
82. 2 5 7 2 4 2 4 10206 2 5 6 1 2 ss lil 2 1 2 Nil 2011 800097 2 4 4 2 3 4 56 2229 9 1 2 8 1 2 2 6 9 3 1 2 2 1 0
83. 3 HPLC CHIRALCEL OD CHIRALPAK AD 41 HPLC CHIRALCE L OD CHIRALPAK AD 7 1 2 5 1 49 5 35 1 9 9 6 Tetrahedron Asymmetry 3 4 9 HPLC 36
84. S 2 2 S 7 1 2 2 1
85. 5 0 0 CHIRALCEL OD CHIRALPAK AD CHIRALCEL OD C HIRALPAK AD Typ e IL 2 6 4 6 4 CHIRALCEL OD CHIRALPA K AD
86. 2 6 2 S 8 1 5 4 1 S 1 2 R 2 R S 2
87. 2 13 S 1 1 1
88. NMR 32 GC 2 2 1 1 HPL C 5 6 7 1 3 1 6 1 2 9 3 1 7 1 4 3 1 6 2 1 1996 8 HPLC 1 a 7 3 1 5 6 6 3 5 34 6 0
89. 4 1 4 h 5ml kg 2 1 25 mg kg 1 1 1 mg kg bp o n 0 01 8 0 _ 0 02 7 42 9 S 0 03 8 62 5 0 06 8 100 0 1 8 100 0 3 8 0 0 6 8 0 R 1 0 8 50 0 3 0 8 62 5 10 0 8 100 np 16 7 homo1ogousP CA P CA 2 3 2 BPO BGG IgE 0 0 5ml
90. 7 7 S S R R S R homologounsPCA S R 1 1 0036 S I S S 0048 S I
91. 1 0 1 CHIRA LCEL OD CHIRALPAK AD Type I 6 4 1 2 3 2 5 8 1 5 4 1 L OD CHIRALPAK AD 6 5 CHIRAL PAK AD 6 4 8 Type
92. 3 52
93. 3 77 19 20 S 5 4 HPLC 2 HPLC 2 HPLC 0 1
94. LPAK AD S R S S S R R S R 2 R 2 R
Download Pdf Manuals
Related Search